MDGL
Madrigal Pharmaceuticals, Inc.
$398.08−23.91 (−5.67%)Close Nov 18, 2026
Loading the growth chart…
Growth of $10,000
Feb 6, 2007 – Nov 18, 2026, Dividends reinvested
- Final balance
- $12,512
- CAGR
- +1.14%
- Max drawdown
- −98.38%
Trailing returns (%)
MDGL's average annual return was 37.47% over the last 10 years, through Nov 18, 2026. $10,000 in MDGL on Nov 18, 2016 grew to $240,969 by Nov 18, 2026, with dividends reinvested.
Total
- 1M
- −11.49%
- 3M
- −24.08%
- 6M
- −23.77%
- YTD
- −31.64%
- 1Y
- −28.79%
Per year
- 3Y
- +31.10%
- 5Y
- +36.71%
- 10Y
- +37.47%
- 15Y
- +7.53%
- Since 2007
- +1.14%
Annual returns
2007 from Feb 6 · 2026 through Nov 18
MDGL returns by year
| Year | Return |
|---|---|
| 2026 through Nov 18 | −31.64% |
| 2025 | +88.72% |
| 2024 | +33.36% |
| 2023 | −20.28% |
| 2022 | +242.52% |
| 2021 | −23.77% |
| 2020 | +22.02% |
| 2019 | −19.17% |
| 2018 | +22.80% |
| 2017 | +516.04% |
| 2016 | +21.63% |
| 2015 | −86.79% |
Metrics
Since 2007| Volatility | 103.56% |
|---|---|
| Sharpe ratio | 0.41 |
| Sortino ratio | 0.84 |
| Calmar ratio | 0.01 |
| Longest drawdown | 12.6 years |
Worst drawdowns
Since 2007| Decline | Peak | Bottom | Recovered | Length |
|---|---|---|---|---|
| −98.4% | Jan 2013 | Feb 2016 | Aug 2025 | 12.6 years |
| −87.6% | Oct 2007 | Feb 2009 | Jan 2013 | 5.3 years |
| −51.4% | Jun 2007 | Aug 2007 | Oct 2007 | 4 months |
| −34.3% | Dec 2025 | Nov 2026 | Not yet | 11 months so far |
| −18.9% | Feb 2007 | Apr 2007 | Jun 2007 | 4 months |